STOCK TITAN

[SCHEDULE 13G] HilleVax, Inc. SEC Filing

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 50,141,064 shares of Common Stock outstanding on May 5, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended March 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 50,141,064 shares of Common Stock outstanding on May 5, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended March 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 50,141,064 shares of Common Stock outstanding on May 5, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended March 31, 2025.


SCHEDULE 13G



EcoR1 Capital, LLC
Signature:/s/ Oleg Nodelman
Name/Title:Manager
Date:07/24/2025
Oleg Nodelman
Signature:/s/ Oleg Nodelman
Name/Title:Reporting person
Date:07/24/2025
EcoR1 Capital Fund Qualified, L.P.
Signature:/s/ Oleg Nodelman
Name/Title:Manager of the General Partner, EcoR1 Capital, LLC
Date:07/24/2025
Exhibit Information

EXHIBIT 99.1 - AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G

Keep reading